Genome-wide pleiotropy between Parkinson disease and autoimmune diseases
Open accessAbstract
Importance: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standing observations of an association between immune-mediated diseases and Parkinson disease (PD). The post-GWAS era provides an opportunity for cross-phenotype analyses between different complex phenotypes. Objectives: To test the hypothesis that there are common genetic risk variants conveying risk of both PD and autoimmune diseases (ie, pleiotropy) and to identify new shared genetic variants and their pathways by applying a novel statistical framework in a genome-wide approach. Design, Setting, and Participants: Using the conjunction false discovery rate method, this study analyzed GWAS data from a selection of archetypal autoimmune diseases among 138 511 individuals of European ancestry and systemically investigated pleiotropy between PD and type 1 diabetes, Crohn disease, ulcerative colitis, rheumatoid arthritis, celiac disease, psoriasis, and multiple sclerosis. NeuroX data (6927 PD cases and 6108 controls) were used for replication. The study investigated the biological correlation between the top loci through protein-protein interaction and changes in the gene expression and methylation levels. The dates of the analysis were June 10, 2015, to March 4, 2017. Main Outcomes and Measures: The primary outcome was a list of novel loci and their pathways involved in PD and autoimmune diseases. Results: Genome-wide conjunctional analysis identified 17 novel loci at false discovery rate less than 0.05 with overlap between PD and autoimmune diseases, including known PD loci adjacent to GAK, HLA-DRB5, LRRK2, and MAPT for rheumatoid arthritis, ulcerative colitis and Crohn disease. Replication confirmed the involvement of HLA, LRRK2, MAPT, TRIM10, and SETD1A in PD. Among the novel genes discovered, WNT3, KANSL1, CRHR1, BOLA2, and GUCY1A3 are within a protein-protein interaction network with known PD genes. A subset of novel loci was significantly associated with changes in methylation or expression levels of adjacent genes. Conclusions and Relevance: The study findings provide novel mechanistic insights into PD and autoimmune diseases and identify a common genetic pathway between these phenotypes. The results may have implications for future therapeutic trials involving anti-inflammatory agents.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Multiple common genetic variants between PD patients and other inflammatory diseases have been identified.
“Multiple common genetic variants between PD patients and other inflammatory diseases have been identified.249,250”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [249]
Genomewide association studies have alluded to a significant genetic overlap between Parkinson's disease and autoimmune diseases.
“Genomewide association studies have alluded to a significant genetic overlap between Parkinson's disease and autoimmune diseases.97”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436 · see citing works
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487 · see citing works
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,024 · see citing works
Self-citationGenome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891 · see citing works
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697 · see citing works
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593 · see citing works
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520 · see citing works
Self-citationGenome-wide association study reveals genetic risk underlying Parkinson's disease
Simón‐Sánchez, J., Schulte, C., Brás, J., Sharma, M., Gibbs, J. R., Berg, D., Paisán‐Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,916 · see citing works
Self-citationInternational Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895 · see citing works
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · see citing works
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746 · see citing works
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554 · see citing works
Anderson, C. A., Boucher, G., Lees, C. W., Franke, A., D’Amato, M., Taylor, K. D., Lee, J. C., Goyette, P., Imielinski, M. B., Latiano, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.764 · Cited by 1,312 · see citing works
Self-citationGenome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
BIRAC Consortium, Stahl, E. A., YEAR Consortium, Raychaudhuri, S., Remmers, E. F., Xie, G., Eyre, S., Thomson, B. P., Li, Y., Kurreeman, F. A. S., et al. (2010) · Nature Genetics · doi:10.1038/ng.582 · Cited by 1,253 · see citing works
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., LAUGHREN, T. P., & Katz, R. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204 · see citing works
Multiple common variants for celiac disease influencing immune gene expression
Dubois, P. C. A., Trynka, G., Franke, L., Hunt, K. A., Romanos, J., Curtotti, A., Zhernakova, A., Heap, G., Ádány, R., Aromaa, A. J., et al. (2010) · Nature Genetics · doi:10.1038/ng.543 · Cited by 1,026 · see citing works
Nalls, M., Plagnol, V., Hernandez, D., Sharma, M., Sheerin, U., Saad, M., Simón-Sánchez, J., Schulte, C., Lesage, S., Sveinbjörnsdóttir, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 986 · see citing works
Efron, B. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511761362 · Cited by 820 · see citing works
Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain
Gibbs, J. R., van der Brug, M. P., Hernandez, D. G., Traynor, B. J., Nalls, M. A., Lai, S.-L., Arepalli, S., Dillman, A., Rafferty, I. P., Troncoso, J., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000952 · Cited by 769 · see citing works
Self-citationTRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761 · see citing works
Genetic variability in the regulation of gene expression in ten regions of the human brain
UK Brain Expression Consortium, Ramasamy, A., North American Brain Expression Consortium, Trabzuni, D., Guelfi, S., Varghese, V., Smith, C., Walker, R., De, T., Coin, L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3801 · Cited by 644 · see citing works
Self-citationNonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. Á., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 630 · see citing works
The bowel and beyond: The enteric nervous system in neurological disorders
Rao, M., & Gershon, M. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.107 · Cited by 629 · see citing works
Inflammation and neurodegeneration in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.005 · Cited by 628 · see citing works
Pervasive Sharing of Genetic Effects in Autoimmune Disease
Cotsapas, C., Voight, B. F., Rossin, E., Lage, K., Neale, B. M., Wallace, C., Abecasis, G. R., Barrett, J. C., Behrens, T., Cho, J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002254 · Cited by 606 · see citing works
Andreassen, O. A., Djurovic, S., Thompson, W. K., Schork, A. J., Kendler, K. S., O’Donovan, M. C., Rujescu, D., Werge, T., van de Bunt, M., Morris, A. P., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.001 · Cited by 506 · see citing works
Self-citationNonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Chen, H., Jacobs, E. J., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Annals of Neurology · doi:10.1002/ana.20682 · Cited by 470 · see citing works
Plots of P-values to evaluate many tests simultaneously
Schweder, T., & Spjøtvoll, E. (1982) · Biometrika · doi:10.1093/biomet/69.3.493 · Cited by 440 · see citing works
Gessner, J. E., Heiken, H., Tamm, A., & Schmidt, R. E. (1998) · Annals of Hematology · doi:10.1007/s002770050396 · Cited by 410 · see citing works
Andreassen, O. A., Thompson, W. K., Schork, A. J., Ripke, S., Mattingsdal, M., Kelsoe, J. R., Kendler, K. S., O’Donovan, M. C., Rujescu, D., Werge, T. M., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003455 · Cited by 402 · see citing works
Self-citationThe UK-PSCSC Consortium, Liu, J. Z., The International IBD Genetics Consortium, The International PSC Study Group, Hov, J. R., Folseraas, T., Ellinghaus, E., Rushbrook, S. M., Doncheva, N. T., Andreassen, O. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2616 · Cited by 391 · see citing works
Self-citationEllinghaus, D., Ellinghaus, E., Nair, R. P., Stuart, P. E., Esko, T., Metspalu, A., Debrus, S., Raelson, J., Tejasvi, T., Belouchi, M., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.020 · Cited by 347 · see citing works
Self-citationThe molecular dissection of Fc gamma receptor mediated phagocytosis
Indik, Z. K., Park, J., HUNTER, S. E., & Schreiber, A. (1995) · Blood · doi:10.1182/blood.v86.12.4389.bloodjournal86124389 · Cited by 313 · see citing works
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
Plagnol, V., Nalls, M., Brás, J., Hernandez, D., Sharma, M., Sheerin, U., Saad, M., Simón-Sánchez, J., Schulte, C., Lesage, S., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002142 · Cited by 304 · see citing works
Daniele, S. G., Béraud, D., Davenport, C., Cheng, K., Yin, H., & Maguire-Zeiss, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005965 · Cited by 303 · see citing works
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martin-Villalba, A., Hengerer, B., Kassubek, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1345-4 · Cited by 295 · see citing works
Neurodegeneration and Inflammation in Parkinson's disease
Phani, S., Loike, J. D., & Przedborski, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70064-5 · Cited by 263 · see citing works
Inflammation and Adaptive Immunity in Parkinson's DiseasePreprint
Mosley, R. L., Hutter-Saunders, J. A. L., Stone, D. K., & Gendelman, H. E. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009381 · Cited by 246 · see citing works
SNAREing immunity: the role of SNAREs in the immune system
Stow, J. L., Manderson, A. P., & Murray, R. Z. (2006) · Nature Reviews Immunology · doi:10.1038/nri1980 · Cited by 235 · see citing works
Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins
Kawai, T., & Akira, S. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100160 · Cited by 231 · see citing works
Inflammation in the early stages of neurodegenerative pathology
Khandelwal, P. J., Herman, A. M., & Moussa, C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 211 · see citing works
Commensal bacteria direct selective cargo sorting to promote symbiosis
Zhang, Q., Pan, Y., Yan, R., Zeng, B., Wang, H., Zhang, X., Li, W., Wei, H., & Liu, Z. (2015) · Nature Immunology · doi:10.1038/ni.3233 · Cited by 206 · see citing works
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2
Cho, D. H., & Tapscott, S. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.013 · Cited by 203 · see citing works
Andreassen, O. A., Harbo, H. F., Wang, Y., Thompson, W. K., Schork, A. J., Mattingsdal, M., Zuber, V., Bettella, F., Ripke, S., Kelsoe, J. R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.195 · Cited by 200 · see citing works
Self-citationUsing genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds335 · Cited by 190 · see citing works
Self-citationAssociation of Parkinson Disease with Structural and Regulatory Variants in the HLA Region
Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189 · see citing works
Corticotropin‐Releasing Hormone and Inflammation
WEBSTER, E. L., Torpy, D. J., Elenkov, I. J., & Chrousos, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09545.x · Cited by 177 · see citing works
Inflammation in autoimmunity: receptors for IgG revisited
Dijstelbloem, H. M. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02014-2 · Cited by 176 · see citing works
Association between genetic traits for immune-mediated diseases and Alzheimer disease
Yokoyama, J. S., Wang, Y., Schork, A. J., Thompson, W. K., Karch, C. M., Cruchaga, C., McEvoy, L. K., Witoelar, A., Chen, C.-H., Holland, D., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0150 · Cited by 176 · see citing works
Self-citationConsensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Holt, R. I. G. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2086 · Cited by 171 · see citing works
Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus
Desikan, R. S., Schork, A. J., Wang, Y., Witoelar, A., Sharma, M., McEvoy, L. K., Holland, D., Brewer, J. B., Chen, C., Thompson, W. K., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.6 · Cited by 141 · see citing works
Self-citationHolmans, P., Moskvina, V., Jones, L., Sharma, M., Vedernikov, A., Büchel, F., Sadd, M., Brás, J., Bettella, F., Nicolaou, N., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds492 · Cited by 139 · see citing works
Self-citationInnate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
Stone, D. K., Reynolds, A. D., Mosley, R. L., & Gendelman, H. E. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2460 · Cited by 130 · see citing works
Li, X., Sundquist, J., & Sundquist, K. (2011) · Neurodegenerative Diseases · doi:10.1159/000333222 · Cited by 129 · see citing works
Monahan, A. J., Warren, M., & Carvey, P. M. (2008) · Cell Transplantation · doi:10.3727/096368908784423328 · Cited by 126 · see citing works
Association between Parkinson's disease and the HLA‐DRB1 locus
Ahmed, I., Tamouza, R., Delord, M., Krishnamoorthy, R., Tzourio, C., Mulot, C., Nacfer, M., Lambert, J., Beaune, P. H., Laurent‐Puig, P., et al. (2012) · Movement Disorders · doi:10.1002/mds.25035 · Cited by 120 · see citing works
Autoimmune disease and risk for Parkinson disease
Rugbjerg, K., Friis, S., Ritz, B. R., Schernhammer, E. S., Korbo, L., & Olsen, J. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c06635 · Cited by 120 · see citing works
Genetic determinants of hair color and parkinson's disease risk
Gao, X., Simon, K. C., Han, J., Schwarzschild, M. A., & Ascherio, A. (2009) · Annals of Neurology · doi:10.1002/ana.21535 · Cited by 116 · see citing works
Large-Scale Inference: Empirical Bayes Methods for Estimation, Testing, and Prediction
Robert, C. P. (2012) · CHANCE · doi:10.1080/09332480.2012.726568 · Cited by 115 · see citing works
PLEKHM1 Regulates Salmonella-Containing Vacuole Biogenesis and Infection
McEwan, D. G., Richter, B. I., Claudi, B., Wigge, C., Wild, P. S., Farhan, H., McGourty, K., Coxon, F. P., Franz‐Wachtel, M., Perdu, B., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.011 · Cited by 105 · see citing works
NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
Nalls, M. A., Brás, J., Hernandez, D. G., Keller, M. F., Majounie, E., Renton, A. E., Saad, M., Jansen, I. E., Guerreiro, R. J., Lubbe, S. J., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.028 · Cited by 98 · see citing works
Self-citationPeters, J. E., Lyons, P., Lee, J. C., Richard, A. C., Fortune, M. D., Newcombe, P. J., Richardson, S. T., & Smith, K. G. C. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005908 · Cited by 93 · see citing works
Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1
Kaliman, P., & Llagostera, E. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.05.005 · Cited by 78 · see citing works
Crucial role of the melanocortin receptor MC1R in experimental colitis
Maaser, C., Kannengiesser, K., Specht, C., Lügering, A., Brzoska, T., Luger, T. A., Domschke, W., & Kucharzik, T. (2006) · Gut · doi:10.1136/gut.2005.083634 · Cited by 74 · see citing works
Genetic comorbidities in Parkinson's disease
Nalls, M. A., Saad, M., Noyce, A. J., Keller, M. F., Schrag, A. E., Bestwick, J., Traynor, B. J., Gibbs, J. R., Hernandez, D. G., Cookson, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt465 · Cited by 72 · see citing works
Self-citationAssociation of the MAPT locus with Parkinson’s disease
Wider, C. W., Vilariño‐Güell, C., Jasińska‐Myga, B., Heckman, M. G., Soto‐Ortolaza, A. I., Cobb, S. A., Aasly, J. O., Gibson, J. M., Lynch, T., Uitti, R. J., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02847.x · Cited by 61 · see citing works
Inflammation and infection in Parkinson's disease.
Arai, H., Furuya, T., Mizuno, Y., & Mochizuki, H. (2006) · PubMed · doi:10.14670/hh-21.673 · Cited by 59 · see citing works
The role of LRRK2 in inflammatory bowel disease
Liu, Z., & Lenardo, M. J. (2012) · Cell Research · doi:10.1038/cr.2012.42 · Cited by 56 · see citing works
Activation of Pre-mRNA Splicing by Human RNPS1 Is Regulated by CK2 Phosphorylation
Trembley, J. H., Tatsumi, S., Sakashita, E., Loyer, P., Slaughter, C. A., Suzuki, H., Endo, H., Kidd, V. J., & Mayeda, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1446-1457.2005 · Cited by 55 · see citing works
Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
Trabzuni, D., Ryten, M., Emmett, W., Ramasamy, A., Lackner, K. J., Zeller, T., WALKER, R. E., Smith, C., Lewis, P. A., Mamais, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070724 · Cited by 50 · see citing works
Self-citationPellegrini, C., Colucci, R., Antonioli, L., Barocelli, E., Ballabeni, V., Bernardini, N., Blandizzi, C., de Jonge, W. J., & Fornai, M. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12933 · Cited by 41 · see citing works
Plots of P-Values to Evaluate Many Tests Simultaneously
Schweder, T., & Spjøtvoll, E. (1982) · Biometrika · doi:10.2307/2335984 · Cited by 40 · see citing works
Parkinsonism in multiple sclerosis
Vieregge, P., Klostermann, W. E. M., & Brückmann, H. (1992) · Movement Disorders · doi:10.1002/mds.870070416 · Cited by 32 · see citing works
The RIT2 and STX1B polymorphisms are associated with Parkinson's disease
Wang, J., Gong, M.-Y., Ye, Y.-L., Ye, J.-M., Lin, G.-L., Zhuang, Q.-Q., Zhang, X., & Zhu, J. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.12.006 · Cited by 29 · see citing works
Franke, L., Bannoudi, H. E., Jansen, D. T. S. L., Kok, K., Trynka, G., Diogo, D., Swertz, M. A., Fransén, K., Knevel, R., Gutierrez‐Achury, J., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.95 · Cited by 28 · see citing works
Weersma, R. K., Crusius, B. J. A., Roberts, R. L., Koeleman, B. P. C., Palomino‐Morales, R., Wolfkamp, S. C., Hollis‐Moffatt, J. E., Festen, E. A. M., Meisneris, S., Heijmans, R., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21342 · Cited by 22 · see citing works
Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe
Blauwendraat, C., Francescatto, M., Gibbs, J. R., Jansen, I. E., Simón‐Sánchez, J., Hernandez, D. G., Dillman, A., Singleton, A., Cookson, M., Rizzu, P., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0320-1 · Cited by 21 · see citing works
Self-citationMultiple sclerosis and risk of P arkinson's disease: a D anish nationwide cohort study
Nielsen, N., Pasternak, B., Stenager, E., Koch–Henriksen, N., & Frisch, M. (2013) · European Journal of Neurology · doi:10.1111/ene.12255 · Cited by 19 · see citing works
Parkinsonism in multiple sclerosis patients: A casual or causal association?
Pedemonte, E., Trabucco, E., Cella, M., & Solaro, C. M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.11.021 · Cited by 15 · see citing works
Holmans, P., Moskvina, V., Jones, L., Sharma, M., Vedernikov, A., Büchel, F., Saad, M., Brás, J., Bettella, F., Nicolaou, N., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt554 · Cited by 13 · see citing works
Self-citation
Flagged first, then by citations
2 of the 84 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [16]16. Nielsen NM, Pasternak B, Stenager E, Koch-Henriksen N, Frisch M. Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study. Eur J Neurol. 2014;21(1):107-111. Medline:24053187
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works
“Multiple common genetic variants between PD patients and other inflammatory diseases have been identified.(249,250) In addition, GWAS have identified several immune-related gene variants in PD,(251) including leucine rich repeat kinase 2 (LRRK2), glucosylceramidase (GBA), parkin RBR E3 ubiquitin protein ligase (PRKN)…”
BackgroundInflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382 · see citing works
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779 · see citing works
Parkinson disease and the immune system - Associations, mechanisms and therapeutics
Tan, E.-K., Chao, Y.-X., West, A., Chan, L.-L., Poewe, W., & Jankovic, J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0344-4 · Cited by 457 · see citing works
Ülgen, E., Özışık, O., & Sezerman, O. U. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00858 · Cited by 456 · see citing works
Microglia and astrocyte dysfunction in parkinson's disease
Kam, T., Hinkle, J. T., Dawson, T. M., & Dawson, V. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105028 · Cited by 399 · see citing works
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392 · see citing works
Peter, I., Dubinsky, M., Bressman, S., Park, A., Lu, C., Chen, N., & Wang, A. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0605 · Cited by 386 · see citing works
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 373 · see citing works
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D. P., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 369 · see citing works
Villumsen, M., Aznar, S., Pakkenberg, B., Jess, T., & Brudek, T. (2018) · Gut · doi:10.1136/gutjnl-2017-315666 · Cited by 315 · see citing works
Yang, C., Farias, F. H. G., Ibanez, L., Suhy, A., Sadler, B., Fernandez, M. V., Wang, F., Bradley, J. L., Eiffert, B., Bahena, J. A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00886-6 · Cited by 290 · see citing works
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281 · see citing works
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J. (2020) · Brain · doi:10.1093/brain/awaa269 · Cited by 267 · see citing works
Discovery of shared genomic loci using the conditional false discovery rate approach
Smeland, O. B., Frei, O., Shadrin, A. A., O’Connell, K. S., Fan, C. C., Bahrami, S., Holland, D., Djurovic, S., Thompson, W. K., Dale, A. M., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-02060-2 · Cited by 249 · see citing works
Self-citationThe Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
Cheong, J. L. Y., Pablo‐Fernández, E. D., Foltynie, T., & Noyce, A. J. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191900 · Cited by 230 · see citing works
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 205 · see citing works
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 198 · see citing works
Immune system responses in Parkinson's disease: Early and dynamic
Tansey, M. G., & Romero‐Ramos, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14290 · Cited by 183 · see citing works
Hughes, C. D., Choi, M. L., Ryten, M., Hopkins, L., Drews, A., Botía, J. A., Iljina, M., Rodrigues, M., Gagliano, S. A., Gandhi, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1907-y · Cited by 177 · see citing works
LRRK2 regulation of immune-pathways and inflammatory disease
Wallings, R. L., & Tansey, M. G. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180463 · Cited by 174 · see citing works
Innate immune activation in neurodegenerative diseases
Castro‐Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 167 · see citing works
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Berwick, D. C., Heaton, G. R., Azeggagh, S., & Harvey, K. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0344-2 · Cited by 164 · see citing works
NADPH oxidases in Parkinson’s disease: a systematic review
Bélarbi, K., Cuvelier, E., Destée, A., Gressier, B., & Chartier‐Harlin, M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0225-5 · Cited by 158 · see citing works
Boyd, R. J., Avramopoulos, D., Jantzie, L. L., & McCallion, A. S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02584-x · Cited by 162 · see citing works
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
Lee, H.-S., Lobbestael, E., Vermeire, S., Sabino, J., & Cleynen, I. (2021) · Gut · doi:10.1136/gutjnl-2020-322429 · Cited by 151 · see citing works
The immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 148 · see citing works
Inflammatory bowel diseases and Parkinson's disease
Brudek, T. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191729 · Cited by 139 · see citing works
The risk of Parkinson’s disease in inflammatory bowel disease: A systematic review and meta-analysis
Zhu, F., Li, C., Gong, J., Zhu, W., Gu, L., & Li, N. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.017 · Cited by 136 · see citing works
The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives
Günther, C., Rothhammer, V., Karow, M., Neurath, M., & Winner, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168870 · Cited by 123 · see citing works
Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease
Kim, S., Eun, H. S., & Jo, E. (2019) · Cells · doi:10.3390/cells8010077 · Cited by 120 · see citing works
Kim, K. S., Marcogliese, P. C., Yang, J., Callaghan, S. M., Resende, V., Abdel-Messih, E., Marras, C., Visanji, N. P., Huang, J., Schlossmacher, M. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718946115 · Cited by 111 · see citing works
Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond
Bayne, A. N., & Trempe, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03203-4 · Cited by 113 · see citing works
The Search for Environmental Causes of Parkinson’s Disease: Moving Forward
Chen, H., & Ritz, B. R. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181493 · Cited by 107 · see citing works
Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
Camacho‐Soto, A., Gross, A., Nielsen, S. S., Dey, N., & Racette, B. A. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.008 · Cited by 102 · see citing works
Smeland, O. B., Shadrin, A. A., Bahrami, S., Broce, I., Tesli, M., Frei, O., Wirgenes, K. V., O’Connell, K. S., Krull, F., Bettella, F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.026 · Cited by 100 · see citing works
Self-citationPark, S., Kim, J., Chun, J., Han, K., Soh, H., Kang, E. A., Lee, H. J., Im, J. P., & Kim, J. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081191 · Cited by 99 · see citing works
Hughes, C. D., Choi, M. L., Ryten, M., Hopkins, L., Drews, A., Botía, J. A., Iljina, M., Rodrigues, M., Taliun, S. A. G., Gandhi, S., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1919-7 · Cited by 99 · see citing works
Parkinson’s disease and diabetes mellitus: common mechanisms and treatment repurposing
Labandeira, C. M., Bau, A. F., Ron, D. A., Álvarez, E., Alba, P. V., Garma, J. L., & Rodriguez-Perez, A. I. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332122 · Cited by 96 · see citing works
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
Santiago, J. A., Bottero, V., & Potashkin, J. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00394 · Cited by 95 · see citing works
Zhu, Y., Yuan, M., Zhu, Y., Yang, F., Chen, W., Xu, Z.-Z., Xiang, Z.-B., & Xu, R.-S. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.317981 · Cited by 94 · see citing works
Videira, P. A., & Castro‐Caldas, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00381 · Cited by 93 · see citing works
Savitt, D., & Jankovic, J. J. (2019) · Drugs · doi:10.1007/s40265-019-01104-1 · Cited by 89 · see citing works
Lee, H., Flynn, R., Sharma, I., Haberman, E. R., Carling, P. J., Nicholls, F. J., Stegmann, M., Vowles, J., Haenseler, W., Wade‐Martins, R., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.04.001 · Cited by 79 · see citing works
The role of T cells in the pathogenesis of Parkinson’s disease
Chen, Z., Chen, S., & Liu, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.08.002 · Cited by 78 · see citing works
The Emerging Immunogenetic Architecture of Schizophrenia
Pouget, J. G. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby038 · Cited by 75 · see citing works
LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s
Wallings, R. L., Herrick, M. K., & Tansey, M. G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00443 · Cited by 77 · see citing works
Intestinal Inflammation and Parkinson’s Disease
Li, Y., Chen, Y., Jiang, L., Zhang, J., Tong, X., Chen, D., & Le, W. (2021) · Aging and Disease · doi:10.14336/ad.2021.0418 · Cited by 74 · see citing works
Chen, S., & Lin, C. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00839-6 · Cited by 81 · see citing works
Shared genetic etiology underlying Alzheimer’s disease and major depressive disorder
Lutz, M. W., Sprague, D., Barrera, J., & Chiba‐Falek, O. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0769-y · Cited by 70 · see citing works
The roles and functions of Paneth cells in Crohn’s disease: A critical review
Yang, E., & Shen, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12958 · Cited by 71 · see citing works
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
Zimmermann, M., & Brockmann, K. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223277 · Cited by 72 · see citing works
Süß, P., Rothe, T., Hoffmann, A., Schlachetzki, J. C. M., & Winkler, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612104 · Cited by 69 · see citing works
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 74 · see citing works
Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies
Wang, T., Shi, C., Luo, H., Zheng, H., Fan, L., Tang, M., Su, Y., Yang, J., Mao, C., & Xu, Y. (2021) · The Neuroscientist · doi:10.1177/1073858421991066 · Cited by 66 · see citing works
Profiling variable-number tandem repeat variation across populations using repeat-pangenome graphs
Lu, T.-Y. T., Munson, K. M., Lewis, A. P., Zhu, Q., Tallon, L. J., Devine, S. E., Lee, C., Eichler, E. E., & Chaisson, M. (2021) · Nature Communications · doi:10.1038/s41467-021-24378-0 · Cited by 60 · see citing works
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63 · see citing works
The systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Lauritsen, J., & Romero‐Ramos, M. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.005 · Cited by 64 · see citing works
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 63 · see citing works
Progress of immunotherapy of anti-α-synuclein in Parkinson's disease.
Wang, Z.-P., Gao, G., Duan, C., & Yang, H. (2019) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2019.108843 · Cited by 48 · see citing works
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease
König, A., Miranda, H. V., & Outeiro, T. F. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171285 · Cited by 59 · see citing works
Thi Lai, T., Kim, Y. E., Nguyen, L. T. N., Thi Nguyen, T., Kwak, I. H., Richter, F., Kim, Y. J., & Ma, H.-I. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00640-2 · Cited by 56 · see citing works
Houser, M. C., Caudle, W. M., Chang, J., Kannarkat, G. T., Yang, Y., Kelly, S. D., Oliver, D. L., Joers, V. L., Shannon, K. M., Keshavarzian, A., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01240-4 · Cited by 54 · see citing works
PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains Treg homeostasis during ageing
Danileviciute, E., Zeng, N., Capelle, C., Paczia, N., Gillespie, M. A. K., Kurniawan, H., Benzarti, M., Merz, M. P., Coowar, D., Fritah, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00576-y · Cited by 57 · see citing works
O'Connell, K., Shadrin, A., Bahrami, S., Smeland, O., Bettella, F., Frei, O., Krull, F., Askeland, R., Walters, G., Davíðsdóttir, K., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0613-z · Cited by 45 · see citing works
Self-citationModeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
Balestri, W., Sharma, R., da Silva, V. A., Bobotis, B. C., Curle, A. J., Kothakota, V., Kalantarnia, F., Hangad, M. V., Hoorfar, M., Jones, J., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03024-8 · Cited by 53 · see citing works
The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
Jiang, T., Li, G., Xu, J., Gao, S., & Xu, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02047 · Cited by 51 · see citing works
Polygenic risk and pleiotropy in neurodegenerative diseases
Bellou, E., Stevenson-Hoare, J. O., & Escott-Price, V. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104953 · Cited by 48 · see citing works
Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases
Li, C. Y., Yang, T. M., Ou, R. W., Wei, Q. Q., & Shang, H. F. (2021) · BMC Medicine · doi:10.1186/s12916-021-01903-y · Cited by 48 · see citing works
Müller-Nedebock, A. C., Dekker, M. C. J., Farrer, M. J., Hattori, N., Lim, S., Mellick, G. D., Rektorová, I., Salama, M., Schuh, A. F. S., Stoessl, A. J., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00535-8 · Cited by 47 · see citing works
Pathogenesis‐targeted therapeutic strategies in Parkinson's disease
Jankovic, J. J. (2018) · Movement Disorders · doi:10.1002/mds.27534 · Cited by 47 · see citing works
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease
Magnusen, A. F., Hatton, S. L., Rani, R., & Pandey, M. K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.636139 · Cited by 47 · see citing works
Domínguez-Fernández, C., Egiguren-Ortiz, J., Razquin, J., Gómez-Galán, M., Heras-García, L. D. L., Paredes-Rodriguez, E., Astigarraga, E., Miguélez, C., & Barreda‐Gómez, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043321 · Cited by 49 · see citing works
Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”
Outeiro, T. F., Alcalay, R. N., Antonini, A., Attems, J., Bonifati, V., Cardoso, F., Chesselet, M., Hardy, J., Madeo, G., McKeith, I. G., et al. (2023) · Movement Disorders · doi:10.1002/mds.29419 · Cited by 47 · see citing works
Self-citationCellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
Jamebozorgi, K., Taghizadeh, E., Rostami, D., Pormasoumi, H., Barreto, G. E., Hayat, S. M. G., & Sahebkar, A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1419-8 · Cited by 45 · see citing works
Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
Golde, T. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.027 · Cited by 45 · see citing works
Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections
Chi, X., Huang, M., Tu, H., Zhang, B., Lin, X., Xu, H., Dong, C., & Hu, X. (2023) · Science China Life Sciences · doi:10.1007/s11427-021-2187-3 · Cited by 45 · see citing works
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms
Schilder, B. M., Navarro, E., & Raj, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105580 · Cited by 42 · see citing works
TRIM31 facilitates K27-linked polyubiquitination of SYK to regulate antifungal immunity
Wang, X., Zhang, H., Shao, Z., Zhuang, W., Sui, C., Liu, F., Chen, X., Hou, J., Kong, L., Liu, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00711-3 · Cited by 40 · see citing works
Trade-offs in aging lung diseases
van Moorsel, C. H. M. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000476 · Cited by 39 · see citing works
Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variants
Schilder, B. M., & Raj, T. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab294 · Cited by 37 · see citing works
Freuer, D., & Meisinger, C. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00318-7 · Cited by 39 · see citing works
Extracellular alpha-synuclein: Sensors, receptors, and responses
Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 37 · see citing works
Cui, G., Li, S., Ye, H., Yang, Y., Huang, Q., Chu, Y., Shi, Z., & Zhang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956005 · Cited by 40 · see citing works
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD
Liang, D., Liu, H., Jin, R., Feng, R., Wang, J., Qin, C., Zhang, R., Chen, Y., Zhang, J., Teng, J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2276296 · Cited by 38 · see citing works
Lerche, S., Zimmermann, M., Wurster, I., Röeben, B., Fries, F. L., Deuschle, C., Waniek, K., Lachmann, I., Gasser, T., Jakobi, M., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.834580 · Cited by 37 · see citing works
Self-citationRheumatoid Arthritis and Risk of Parkinson Disease in Korea
Kang, J., Eun, Y., Jang, W., Cho, M. H., Han, K., Jung, J., Kim, Y., Kim, G.-T., Shin, D. W., & Kim, H. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.0932 · Cited by 35 · see citing works
Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
Rajamani, K. T., Li, P., Galvis, M. L. E., Labrie, V., Brundin, P., & Brundin, L. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171240 · Cited by 35 · see citing works
Li, M., Wan, J., Xu, Z., & Tang, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1103053 · Cited by 32 · see citing works
Iba, M., Kim, C., Florio, J. B., Mante, M., Adame, A., Rockenstein, E. M., Kwon, S., Rissman, R. A., & Masliah, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00286 · Cited by 32 · see citing works
RetractedGrathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-3326 · Cited by 32 · see citing works
Drug repurposing strategies of relevance for Parkinson’s disease
Fletcher, E. J. R., Kaminski, T. W., Williams, G. H., & Duty, S. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.841 · Cited by 30 · see citing works
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, T. T., Kim, Y. J., Ma, H.-I., & Kim, Y. E. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.21078 · Cited by 32 · see citing works
Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses
Baranova, A. V., Cao, H., & Zhang, F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.738687 · Cited by 32 · see citing works
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
Dong, S., Sun, M., He, C. H., & Cheng, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.015 · Cited by 32 · see citing works
Genetic overlap between Parkinson’s disease and inflammatory bowel disease
Kang, X., Ploner, A., Wang, Y., Ludvigsson, J. F., Williams, D. M., Pedersen, N. L., & Wirdefeldt, K. (2022) · Brain Communications · doi:10.1093/braincomms/fcad002 · Cited by 32 · see citing works
Self-citationBoles, J. S., Krueger, M. E., Jernigan, J. E., Cole, C. L., Neighbarger, N. K., Huarte, O. U., & Tansey, M. G. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.007 · Cited by 31 · see citing works
Cheng, W., Zhu, Q., & Zhang, H. (2020) · Genes · doi:10.3390/genes11091100 · Cited by 31 · see citing works
Induced pluripotent stem cell‐based modeling of mutant LRRK 2‐associated Parkinson's disease
Weykopf, B., Haupt, S., Jungverdorben, J., Flitsch, L. J., Hebisch, M., Liu, G., Suzuki, K., Belmonte, J. C. I., Peitz, M., Blaess, S., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14345 · Cited by 29 · see citing works
Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
Chao, Y., Gulam, M. Y., Chia, N. S. J., Feng, L., Rötzschke, O., & Tan, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00849 · Cited by 32 · see citing works
- Authors
- Witoelar, A., Jansen, I. E., Wang, Y., Desikan, R. S., Gibbs, J. R., Blauwendraat, C., Thompson, W. K., Hernandez, D. G., Djurovic, S., Schork, A. J., Bettella, F., Ellinghaus, D., Franke, A., Lie, B. A., McEvoy, L. K., Karlsen, T. H., Lesage, S., Morris, H. R., Brice, A., Wood, N. W., Heutink, P., Hardy, J., Singleton, A. B., Dale, A. M., Gasser, T., Andreassen, O. A., Sharma, M., & for the International Parkinson’s Disease Genomics Consortium (IPDGC), N. A. B. E. C. (.
- Affiliations
- Oslo University Hospital (NO)
- German Center for Neurodegenerative Diseases (DE)
- University of Oslo (NO)
- University of California, San Francisco (US)
- National Institutes of Health (US)
- University of Copenhagen (DK)
- University of California San Diego (US)
- Christian-Albrechts-Universität zu Kiel (DE)
- Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany
- Centre National de la Recherche Scientifique (FR)
- National Hospital for Neurology and Neurosurgery (GB)
- UCL Queen Square Institute of Neurology (GB)
- University College London (GB)
- Hertie Institute for Clinical Brain Research (DE)
- Corresponding author
- Sharma, Manu
- ORCID
- Witoelar, Aree
- Jansen, Iris E.
- Wang, Yunpeng
- Desikan, Rahul S.
- Gibbs, J. Raphael
- Blauwendraat, Cornelis
- Thompson, Wesley K.
- Hernandez, Dena G.
- Djurovic, Srdjan
- Schork, Andrew J.
- Bettella, Francesco
- Ellinghaus, David
- Lie, Benedicte A.
- McEvoy, Linda K.
- Karlsen, Tom H.
- Lesage, Suzanne
- Morris, Huw R.
- Brice, Alexis
- Wood, Nicholas W.
- Heutink, Peter
- Hardy, John
- Singleton, Andrew B.
- Dale, Anders M.
- Gasser, Thomas
- Andreassen, Ole A.
- Sharma, Manu
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-07-01
- Volume
- 74
- Issue
- 7
- Pages
- 780
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC5710535
- OpenAlex
- W2622719965
- Semantic Scholar
- 77f8aa61d1d32875fc37fcce3fe356cd20cd596e
- Cited by
- 352
- References
- 84
- Citations by year
- 2026: 14 · 2025: 39 · 2024: 60 · 2023: 41 · 2022: 39 · 2021: 62 · 2020: 34 · 2019: 30 · 2018: 24 · 2017: 7
- FWCI
- 18.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, cc-by)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Biogen
- Washington University in St. Louis
- Johns Hopkins University
- University of Rochester
- Wellcome Trust
- Sandwell and West Birmingham Hospitals NHS Trust
- University Hospitals Birmingham NHS Foundation Trust
- Université de Lille
- Parkinson's UK (G-0907, J-0901, J-1402, K-1501)
- Imperial College London
- University College London
- University of Oxford
- Newcastle University
- Cardiff University
- University of Aberdeen
- Institut National de la Santé et de la Recherche Médicale
- Universiteit Leiden
- Universiteit van Amsterdam
- Radboud Universiteit
- Vrije Universiteit Amsterdam
- Eberhard Karls Universität Tübingen
- Centre National de la Recherche Scientifique
- Leids Universitair Medisch Centrum
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Université Pierre et Marie Curie
- National Institutes of Health
- Genentech
- Medical Research Council
- Erasmus Universitair Medisch Centrum Rotterdam
- Helmholtz Zentrum München
- National Human Genome Research Institute
- National Institute of General Medical Sciences (R01GM104400)
- National Institute of Neurological Disorders and Stroke
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Keywords
- Parkinson's disease, autoimmune disease, pleiotropy, type 1 diabetes, Crohn's disease, ulcerative colitis, rheumatoid arthritis, celiac disease, psoriasis, multiple sclerosis, LRRK2, HLA, MAPT, SETD1A, protein-protein interaction network, DNA methylation, gene expression, anti-inflammatory therapy
- MeSH terms
- Arthritis, Rheumatoid, Autoimmune Diseases, Celiac Disease, Colitis, Ulcerative, Crohn Disease, Diabetes Mellitus, Type 1, Humans, Multiple Sclerosis, Parkinson Disease, Psoriasis, Risk Factors, Genetic Predisposition to Disease, Genome-Wide Association Study, Genetic Loci, Genetic Pleiotropy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
